Premium
Influenza B virus infection and Stevens–Johnson syndrome
Author(s) -
Tamez Rebecca L.,
Tan Whitney V.,
O'Malley John T.,
Broder Karen R.,
Garzon Maria C.,
LaRussa Philip,
Lauren Christine T.
Publication year - 2017
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13370
Subject(s) - medicine , oseltamivir , virus , virology , immunology , covid-19 , infectious disease (medical specialty) , disease
A 2‐year‐old boy with influenza B infection and rapidly worsening targetoid skin lesions with mucosal involvement was diagnosed with Stevens–Johnson syndrome (SJS) and treated with oseltamivir and intravenous immunoglobulin, with resolution of illness. Subsequent quadrivalent inactivated influenza vaccine was well tolerated. This case highlights the rarity of SJS in the setting of influenza B infection and addresses the safety of administering subsequent influenza vaccines to such individuals.